The Collaborative Human Tissue Network (CHTN) is a national research tissue procurement group to assist translational investigators both in the academic and commercial research setting with emphasis on cancer research. National Cancer Institute (NCI) funded investigators have priority for service through this group.

The Midwestern Division of CHTN (MW CHTN) is located at The Ohio State University and has been granted funds from the NCI/NIH to distribute prospectively procured, investigator defined, high quality surgical remnant pre-malignant, malignant, benign, diseased and normal biospecimens to funded, IRB approved investigators. This research service is subsidized but not fully supported by the NCI grant. A small fee set by the national CHTN and NCI is collected from investigators to supplement the cost of specimen procurement.

Biospecimens are procured for the MW CHTN supported investigators by the Research Tissue Procurement Service (RTPS) of the Department of Pathology/Human Tissue Research Network (HTRN). The MW CHTN disbursed 49,372 high quality biospecimens with associated limited data sets to 924 investigators from 2008 to 2012. The national CHTN (five divisions) has disbursed over one million biosamples since the initiation of this NCI supported program in 1987.

Individual research consultation and additional laboratory services are available to interested investigators or investigators in need of assistance at any time during their research protocol development and deployment.

The Midwestern Division also works with NCI and other CHTN divisions to advance biospecimen science as well as to improve data management and the availability of quality biospecimens for cutting edge translational research.

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 460 W. 10th Avenue, Columbus, OH 43210 Phone: 1-800-293-5066 | Email: